News
-
-
-
-
-
PRESS RELEASE
Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Aurisco Pharmaceutical, a global Oligonucleotide and Peptide manufacturer, becomes the first generic oligonucleotide API manufacturer in the world to pass USFDA inspection. The inspection sets a new standard for safe and affordable oligonucleotides -
-
-
PRESS RELEASE
EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Brockhaus Technologies AG reports preliminary revenue of €13.4 million and adjusted EBITDA of €-0.5 million for H1 2026, with forecast for continuing operations unchanged -
-
PRESS RELEASE
Voltalia announces an upcoming investment by the International Finance Corporation of up to €120 million in preferred shares of Voltalia’s subsidiary, convertible in ordinary shares of Voltalia, subject to shareholders’ approval
Voltalia announces €120 million investment by International Finance Corporation in Voltalia Management International, subject to shareholder approval. Investment to support renewable energy assets